Search results
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 52 minutes agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical...
Sernova Appoints Jonathan Rigby to its Board of Directors
NewMediaWire via Yahoo Finance· 39 minutes agoLONDON, Ontario and BOSTON, MA - (NewMediaWire) - May 28, 2024 - Sernova Corp. (TSX:SVA)...
The Biggest Biotechnology Company in Europe
Insider Monkey via Yahoo Finance· 1 day agoWe’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry...
Vir Biotechnology Inc [VIR] stock was sold by De Backer Marianne at the price of US$0.69 million –...
Knox Daily· 1 day agoVir Biotechnology Inc’s filing revealed that its Chief Executive Officer De Backer Marianne unloaded Company’s shares for reported $0.69 million on Apr 03 ’24. In the deal ...
Chinese firm addressing FDA concerns over Durham facility - Triangle Business Journal
The Business Journals· 2 hours agoA Chinese biotechnology company is trying to address concerns from federal regulators about a...
With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional...
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Given the large stake in the stock by institutions, Puma Biotechnology's stock price...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 4 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Swiss National Bank Reduces Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
ETF DAILY NEWS· 7 hours agoSwiss National Bank decreased its holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 10.3% during the fourth quarter, according to the company in its most recent ...
CollPlant Biotechnologies (CLGN) Set to Announce Quarterly Earnings on Wednesday
ETF DAILY NEWS· 6 days agoCollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 29th. Analysts expect the company to announce ...
Insmed’s stock rockets toward a 2-decade high after positive drug-trial data
Market Watch· 33 minutes agoShares of Insmed Inc. skyrocketed Tuesday, after the biopharmaceutical company said it plans to file a New Drug Application for its treatment of non-cystic fibrosis bronchiectasis following ...